leftspacer middlespacer rightspacer
Research Menu
Featured Material

MAPS Bulletin Summer 2014: Research Edition
Research > MDMA-Assisted Psychotherapy

MDMA-Assisted Psychotherapy for PTSD: Boulder, Colorado (Intern Study)

The next phase (Phase 3) of our clinical development plan for MDMA-assisted psychotherapy for PTSD will require many more male/female co-therapist teams than are currently available. Finding a cost-effective and sustainable way to recruit effective therapists is therefore a top priority.

In this pilot study, we are investigating the effectiveness of MDMA-assisted psychotherapy for PTSD when one member of the standard male/female co-therapist team is a healthcare intern (being trained in therapy, social work, or nursing). The other member of the team will be a professional therapist trained in our treatment method. As interns work for free in exchange for fulfilling required training hours under professional supervision, this approach would reduce costs and train the next generation of psychedelic therapists.

Principal Investigator: Marcela Ot'alora, M.A., L.P.C.
Location: Boulder, CO

Subjects will be U.S. veterans with PTSD, mostly from Iraq, Afghanistan, or Vietnam, along with survivors of childhood sexual abuse, assault, rape, and others.

This study has been cleared by the Food and Drug Administration and approved by the Drug Enforcement Administration and an Institutional Review Board.

$711,000 estimated study cost • $290,000 raised • $421,000 still needed

Please consider donating today to help this study.

Data management provided by

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.

0.6696 seconds / 93 queries